Follow
Ozen Oz Gul
Ozen Oz Gul
Bursa Uludağ Üniversitesi Tıp Fakültesi
Verified email at uludag.edu.tr
Title
Cited by
Cited by
Year
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
Y Yilmaz, E Ulukaya, OO Gul, M Arabul, CB Gul, O Atug, AY Oral, S Aker, ...
Clinical biochemistry 42 (9), 802-807, 2009
692009
Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in patients with type-1 diabetes mellitus
N Cinkilic, S Kiyici, S Celikler, O Vatan, OO Gul, E Tuncel, R Bilaloglu
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 676 (1-2 …, 2009
472009
Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)
A Sonmez, C Haymana, F Bayram, S Salman, OS Dizdar, E Gurkan, ...
Diabetes research and clinical practice 146, 138-147, 2018
362018
Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients
S Kiyici, C Ersoy, A Kaderli, M Fazlioglu, F Budak, C Duran, OO Gul, ...
Diabetes research and clinical practice 86 (1), 44-50, 2009
362009
Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients
OO Gul, E Tuncel, Y Yilmaz, E Ulukaya, CB Gul, S Kiyici, AY Oral, M Guclu, ...
Metabolism 59 (1), 64-69, 2010
332010
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
M Kayikcioglu, L Tokgozoglu, M Yilmaz, L Kaynar, M Aktan, RB Durmuş, ...
Atherosclerosis 270, 42-48, 2018
282018
Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome
OO Gul, S Cander, B Gul, E Açıkgoz, E Sarandol, C Ersoy
European cytokine network 26 (4), 73-78, 2015
272015
Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity
S Kiyici, OO Gul, EB Baskan, S Hacioglu, F Budak, E Erturk, S Imamoglu
Clinical and Experimental Dermatology: Clinical dermatology 35 (6), 603-607, 2010
262010
Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center
M Calapkulu, S Cander, OO Gul, C Ersoy
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13 (2), 1031-1034, 2019
252019
Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: a cross-sectional …
OO Gul, N Cinkilic, CB Gul, S Cander, O Vatan, C Ersoy, D Yılmaz, ...
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 757 (1 …, 2013
222013
What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
M Kayikcioglu, L Tokgozoglu, V Dogan, C Ceyhan, A Tuncez, M Kutlu, ...
Atherosclerosis 277, 341-346, 2018
172018
Prevalence and correlates of erectile dysfunction in type 2 diabetes mellitus: a cross-sectional single-center study among Turkish patients
S Cander, S Coban, S Altuner, O Oz Gul, ZA Yetgin, A Akkurt, H Ucar, ...
Metabolic syndrome and related disorders 12 (6), 324-329, 2014
162014
Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: results of …
M Kayikcioglu, O Kuman-Tunçel, S Pirildar, M Yílmaz, L Kaynar, M Aktan, ...
Journal of Clinical Lipidology 13 (3), 455-467, 2019
142019
Relationship between glycemic control, microalbuminuria and cognitive functions in elderly type 2 diabetic patients
CB Gul, O Oz Gul, S Cander, A Eroglu, M Hartavi, N Keni, A Bayindir, ...
Renal Failure 36 (8), 1258-1262, 2014
132014
Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection
YA Ünsal, ÖÖ Gül, S Cander, C Ersoy, E Aydemir, C Ateş, Z Uzun, ...
Journal of Endocrinological Investigation 44 (12), 2601-2607, 2021
122021
Does metabolic syndrome increase erectile dysfunction and lower urinary tract symptoms?
S Coban, S Cander, MS Altuner, I Keles, OO Gul
Urology Journal 11 (4), 1820, 2014
122014
Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy
S Kiyici, C Ersoy, OO Gul, E Sarandol, M Demirci, E Tuncel, D Sigirli, ...
Experimental and clinical endocrinology & diabetes 117 (08), 386-390, 2009
122009
An unusual case of adult-onset multi-systemic Langerhans cell histiocytosis with perianal and incident thyroid involvement
OO Gul, P Sisman, S Cander, E Gozden, M Kurt, O Saraydaroglu, T Kirdak, ...
Endocrinology, Diabetes & Metabolism Case Reports 2017 (1), 2017
102017
The prevalence of obesity and related factors: An urban survey study
AG Salici, P Sisman, OO Gul, T Karayel, S Cander, C Ersoy
Endocrine Abstracts 49, 2017
92017
Effect of rosiglitazone and insulin combination therapy on inflammation parameters and adipocytokine levels in patients with type 1 DM
M Guclu, O Oz Gul, S Cander, O Unal, G Ozkaya, E Sarandol, C Ersoy
Journal of Diabetes Research 2015, 2015
92015
The system can't perform the operation now. Try again later.
Articles 1–20